您的购物车当前为空
别名 PF06647263, anti-EFNA4-ADC
PF-06647263 (anti-EFNA4-ADC)是一种靶向 EFNA4-ADC 的 ADC 化合物,具有抗肿瘤活性,由与卡利希霉素载荷相连的抗 EFNA4 抗体组成,诱导 TNBC 异种移植瘤中的肿瘤显著消退。
PF-06647263 (anti-EFNA4-ADC)是一种靶向 EFNA4-ADC 的 ADC 化合物,具有抗肿瘤活性,由与卡利希霉素载荷相连的抗 EFNA4 抗体组成,诱导 TNBC 异种移植瘤中的肿瘤显著消退。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,897 | In stock | |
| 5 mg | ¥ 11,488 | In stock | |
| 10 mg | ¥ 18,380 | In stock | |
| 25 mg | ¥ 34,460 | In stock |
PF-06647263 相关产品
| 产品描述 | PF-06647263 (anti-EFNA4-ADC) is an ADC compound targeting EFNA4, with anti-tumor activity, composed of an anti-EFNA4 antibody conjugated with calicheamicin, inducing significant tumor regression in TNBC xenografts. |
| 靶点活性 | 293T-EFNA4 cells:1 ng/mL (EC50) |
| 体外活性 | PF-06647263 引发抗原和浓度依赖性细胞毒性,暴露于 PF-06647263 96 小时会导致 293T-EFNA4 细胞死亡 (EC50 ≈ 1 ng/mL)。[1] |
| 体内活性 | 在乳腺 PDX 肿瘤模型小鼠中,0.27 mg/kg PF-06647263 导致显著的肿瘤消退。[1] |
| 别名 | PF06647263, anti-EFNA4-ADC |
| 分子量 | 145.5 kDa |
| CAS No. | 1822383-65-2 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容